Ac-AKFVAAWTLKAAA-NH2

Ref. 3D-PP48365

Informations sur le produit

• Nom: Ac-AKFVAAWTLKAAA-NH2

Description

Peptide Ac-AKFVAAWTLKAAA-NH2 is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using Ac-AKFVAAWTLKAAA-NH2 include the following: An altered peptide ligand for naaca¯ve cytotoxic T lymphocyte epitope of TRP-2(180-188) enhanced immunogenicity Y Tang, Z Lin, B Ni, J Wei, J Han, H Wang - Cancer Immunology , 2007 - Springerhttps://link.springer.com/article/10.1007/s00262-006-0195-x Synthesis of multicomponent peptide-based vaccine candidates against group A streptococcus WM Hussein , J Xu, P Simerska - Australian Journal of , 2016 - CSIRO Publishinghttps://www.publish.csiro.au/ch/CH16501 A novel HLA-A2-restricted CTL epitope of tumor-associated antigen L6 can inhibit tumor growth in vivo SH Tu, HI Huang , SI Lin, HY Liu, YP Sher - Journal of , 2012 - journals.lww.comhttps://journals.lww.com/immunotherapy-journal/FullText/2012/04000/A_Novel_HLA_A2_restricted_CTL_Epitope_of.4.aspx Improved immunogenicity against a Her2/neu-Derived peptide by employment of a Pan HLA DR-Binding epitope and CpG in a BALB/c mice model S Tahaghoghi-Hajghorbani - Anti-Cancer Agents , 2017 - ingentaconnect.comhttps://www.ingentaconnect.com/content/ben/acamc/2017/00000017/00000006/art00010 Single-chain HLA-A2 MHC trimers that incorporate an immundominant peptide elicit protective T cell immunity against lethal West Nile virus infection S Kim, L Li, CP McMurtrey, WH Hildebrand - The Journal of , 2010 - journals.aai.orghttps://journals.aai.org/jimmunol/article/184/8/4423/82445 Peptide-based vaccines RJ Nevagi , I Toth , M Skwarczynski - Peptide applications in biomedicine , 2018 - Elsevierhttps://www.sciencedirect.com/science/article/pii/B9780081007365000120 A chimera containing CD4+ and CD8+ T-cell epitopes of the Leishmania donovani nucleoside hydrolase (NH36) optimizes cross-protection against MV Alves-Silva, D Nico , A Morrot, M Palatnik - Frontiers in , 2017 - frontiersin.orghttps://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2017.00100 Immunological evaluation of a novel HLA-A2 restricted phosphopeptide of tumor associated Antigen, TRAP1, on cancer therapy MH Lin, KY Shen, BS Liu, IH Chen, YP Sher , GC Tseng - Vaccine: X, 2019 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S259013621930018X Identification of HLA-A11-restricted CTL epitopes derived from HPV type 18 using DNA immunization HW Chen, CH Leng, HY Liu, WF Cheng - Cancer Biology & , 2009 - Taylor & Francishttps://www.tandfonline.com/doi/pdf/10.4161/cbt.8.21.9732 Human immunome, bioinformatic analyses using HLA supermotifs and the parasite genome, binding assays, studies of human T cell responses, and immunization of H Cong, EJ Mui, WH Witola, J Sidney , J Alexander - Immunome , 2010 - Springerhttps://link.springer.com/article/10.1186/1745-7580-6-12 based on chimeric peptides from different Leishmania infantum proteins induces dendritic cells maturation and promotes peptide-specific IFNγ-producing E Athanasiou, M Agallou , S Tastsoglou - Frontiers in , 2017 - frontiersin.orghttps://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2017.00684/full Epitope targeting with self-assembled peptide vaccines DF Zeigler , E Gage, R Roque, CH Clegg - npj Vaccines, 2019 - nature.comhttps://www.nature.com/articles/s41541-019-0125-5 Improving therapeutic HPV peptide-based vaccine potency by enhancing CD4+ T help and dendritic cell activation CY Wu, A Monie, X Pang, CF Hung , TC Wu - Journal of biomedical , 2010 - Springerhttps://link.springer.com/article/10.1186/1423-0127-17-88 Peptide and peptidomimetic-based vaccines A Singh , M Thakur - Peptide and Peptidomimetic Therapeutics, 2022 - Elsevierhttps://www.sciencedirect.com/science/article/pii/B978012820141100008X

• Marque: Biosynth